Rein Therapeutics, Inc. Long-term Construction Loan, Noncurrent
Rein Therapeutics, Inc. (RNTX) had Long-term Construction Loan, Noncurrent of $5.34 million as of 2018-12-31, per its 10-K filed 2020-03-30.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:ConstructionLoanNoncurrent · last filed 2020-03-30
- 2018-12-31: Long-term Construction Loan, Noncurrent $5.34M.
- 2018-09-30: Long-term Construction Loan, Noncurrent $5.00M.
- 2018-06-30: Long-term Construction Loan, Noncurrent $3.35M.
| Period end | Long-term Construction Loan, Noncurrent |
|---|---|
| 2018-12-31 | $5.34M 10-K · filed 2020-03-30 |
| 2018-09-30 | $5.00M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $3.35M 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |